NASH Summit 2020
Digital, 15-18 Dec 2020
We are looking forward to attending the 4th Annual NASH Summit digitally on 15th - 18th December.
This conference gathers NASH drug developers to share their thoughts across discovery, translational, non-invasive biomarker and clinical drug development tracks, as well as new content on clinical safety, pathological fibrosis and market access. There will be 80+ speakers and 350+ attendees.
Howard Kartstein, Senior Business Development Manager at Owlstone Medical, will be representing us at this meeting.
To meet with us at this event, please get in touch.
Breath Biopsy®
Learn more about breath biomarkers for disease in our free ebook: Breath Biopsy: The Complete Guide.
